To replicate or not to replicate: achieving selective oncolytic virus replication in cancer cells through translational control.

Abstract:

:To ensure that their mRNAs are translated and that the viral proteins necessary for assembling the next generation of infectious progeny are produced, viruses must effectively seize control of the translational machinery within their host cells. In many cases, the ability to productively engage host translational components can determine if a given cell type can support viral replication, illustrating the critical importance of this task in the viral life cycle. Failure to interface properly with the host translational apparatus can compromise the productive growth cycle, resulting in an abortive infection and radically restricting viral replication. Not only have viruses become facile at commandeering this machinery, they are also particularly adept at manipulating cellular translation control pathways for their own ends. In this review, the mechanisms by which numerous viruses manipulate host translational control circuits are discussed. Furthermore, particular attention is devoted to understanding how interfering with the ability of a virus to properly regulate translation in its host can be exploited to generate oncolytic strains that selectively replicate in cancer cells.

journal_name

Oncogene

journal_title

Oncogene

authors

Mohr I

doi

10.1038/sj.onc.1209053

subject

Has Abstract

pub_date

2005-11-21 00:00:00

pages

7697-709

issue

52

eissn

0950-9232

issn

1476-5594

pii

1209053

journal_volume

24

pub_type

杂志文章,评审

相关文献

ONCOGENE文献大全
  • DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7.

    abstract::Constitutively active AR-V7, one of the major androgen receptor (AR) splice variants lacking the ligand-binding domain, plays a key role in the development of castration-resistant prostate cancer (CRPC) and anti-androgen resistance. However, our understanding of the regulatory mechanisms of AR-V7-driven transcription ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-017-0047-5

    authors: Moon SJ,Jeong BC,Kim HJ,Lim JE,Kwon GY,Kim JH

    更新日期:2018-03-01 00:00:00

  • Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.

    abstract::Amplification of the N-myc gene is a significant adverse prognostic factor in neuroblastoma, a common childhood tumor. In non-transformed cells, myc expression is controlled through an autoregulatory circuit, through which elevated Myc protein levels lead to down-regulation of myc transcription. The precise mechanism ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201363

    authors: Sivak LE,Tai KF,Smith RS,Dillon PA,Brodeur GM,Carroll WL

    更新日期:1997-10-16 00:00:00

  • MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF.

    abstract::Esophageal cancer is one of the most lethal cancers worldwide with poor survival and limited therapeutic options. The discovery of microRNAs created a new milestone in cancer research. miR-377 is located in chromosome region 14q32, which is frequently deleted in esophageal squamous cell carcinoma (ESCC), but the biolo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.29

    authors: Li B,Xu WW,Han L,Chan KT,Tsao SW,Lee NPY,Law S,Xu LY,Li EM,Chan KW,Qin YR,Guan XY,He QY,Cheung ALM

    更新日期:2017-07-13 00:00:00

  • MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma.

    abstract::MicroRNAs (miRNAs) may function as either oncogenes or tumor suppressors in the malignant progression of different tumor types. MiR-663 was recently reported to be decreased and identified as a tumor suppressor in gastric cancer. We also verified its role in repressing cell proliferation of a gastric cancer cell line....

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.629

    authors: Yi C,Wang Q,Wang L,Huang Y,Li L,Liu L,Zhou X,Xie G,Kang T,Wang H,Zeng M,Ma J,Zeng Y,Yun JP

    更新日期:2012-10-11 00:00:00

  • Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.

    abstract::Although TGF-beta1, a growth inhibitor, is known to also induce apoptosis, the molecular mechanism of this apoptosis is largely undefined. Here, we identify the mechanism of TGF-beta1-induced apoptosis in SNU-16 human gastric cancer cells. Cell cycle and TUNEL analysis showed that, upon TGF-beta1 treatment, cells were...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204203

    authors: Kim SG,Kim SN,Jong HS,Kim NK,Hong SH,Kim SJ,Bang YJ

    更新日期:2001-03-08 00:00:00

  • RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells.

    abstract::The S-phase kinase-associated protein-2 (SKP2) plays a key role in ubiquitin-mediated proteolysis, which results in the progression of cells from a quiescence to proliferative state. SKP2 is overexpressed in a variety of tumors. In this study, we used small interfering RNAs (siRNAs) to inhibit the SKP2 expression in l...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208459

    authors: Jiang F,Caraway NP,Li R,Katz RL

    更新日期:2005-05-12 00:00:00

  • A CRISPR-based base-editing screen for the functional assessment of BRCA1 variants.

    abstract::Genetic mutations in BRCA1, which is crucial for the process of DNA repair and maintenance of genomic integrity, are known to increase markedly the risk of breast and ovarian cancers. Clinical genetic testing has been used to identify new BRCA1 variants; however, functional assessment and determination of their pathog...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0968-2

    authors: Kweon J,Jang AH,Shin HR,See JE,Lee W,Lee JW,Chang S,Kim K,Kim Y

    更新日期:2020-01-01 00:00:00

  • Survivin, versatile modulation of cell division and apoptosis in cancer.

    abstract::Survivin is a member of the inhibitor of apoptosis (IAP) gene family that has attracted attention from several viewpoints of basic and translational research. Its cell cycle-regulated expression at mitosis and association with the mitotic apparatus have been of interest to cell biologists studying faithful segregation...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1207113

    authors: Altieri DC

    更新日期:2003-11-24 00:00:00

  • NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs.

    abstract::Histone deacetylases (HDACs) catalyse the removal of acetyl groups from the N-terminal tails of histones. All known HDACs can be categorized into one of four classes (I-IV). The class III HDAC or silencing information regulator 2 (Sir2) family exhibits characteristics consistent with a distinctive role in regulation o...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1210617

    authors: Vaquero A,Sternglanz R,Reinberg D

    更新日期:2007-08-13 00:00:00

  • Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.

    abstract::Advanced Bladder Cancer (BLCA) remains a clinical challenge that lacks effective therapeutic measures. Here, we show that distinct, stage-wise metabolic alterations in BLCA are associated with the loss of function of aldehyde oxidase (AOX1). AOX1 associated metabolites have a high predictive value for advanced BLCA an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0902-7

    authors: Vantaku V,Putluri V,Bader DA,Maity S,Ma J,Arnold JM,Rajapakshe K,Donepudi SR,von Rundstedt FC,Devarakonda V,Dubrulle J,Karanam B,McGuire SE,Stossi F,Jain AK,Coarfa C,Cao Q,Sikora AG,Villanueva H,Kavuri SM,Lotan Y

    更新日期:2020-10-01 00:00:00

  • Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells.

    abstract::The ability of glioma cells to migrate great distances from a primary tumor mass is the primary cause of tumor recurrence. The urokinase-type plasminogen activator (uPA) is a serine protease that can initiate proteolytic cascades, which result in remodeling of extracellular matrix and basement membrane, allowing cells...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206164

    authors: Chandrasekar N,Mohanam S,Gujrati M,Olivero WC,Dinh DH,Rao JS

    更新日期:2003-01-23 00:00:00

  • ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT.

    abstract::The crizotinib-resistant ALK(F1174L) mutation arises de novo in neuroblastoma (NB) and is acquired in ALK translocation-driven cancers, lending impetus to the development of novel anaplastic lymphoma kinase (ALK) inhibitors with different modes of action. The diaminopyrimidine TAE684 and its derivative ceritinib (LDK3...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.434

    authors: Debruyne DN,Bhatnagar N,Sharma B,Luther W,Moore NF,Cheung NK,Gray NS,George RE

    更新日期:2016-07-14 00:00:00

  • Copine-I represses NF-kappaB transcription by endoproteolysis of p65.

    abstract::Nuclear factor-kappaB (NF-kappaB) is a dynamic transcription factor that regulates important biological processes involved in cancer initiation and progression. Identifying regulators that control the half-life of NF-kappaB is important to understanding molecular processes that control the duration of transcriptional ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1211030

    authors: Ramsey CS,Yeung F,Stoddard PB,Li D,Creutz CE,Mayo MW

    更新日期:2008-06-05 00:00:00

  • Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5'-RACE and LA - PCR analyses of biopsy samples.

    abstract::In order to elucidate the molecular mechanism(s) for BCL6 translocation, we identified translocational partner genes by subjecting clinical biopsy samples from patients with non-Hodgkin's lymphoma to 5'-rapid amplification of cDNA ends (5'-RACE). Sequence analysis of the 5'-RACE product revealed that the BCL6 gene was...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203293

    authors: Yoshida S,Kaneita Y,Aoki Y,Seto M,Mori S,Moriyama M

    更新日期:1999-12-23 00:00:00

  • Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.

    abstract::Protein-protein interaction can play an important role in the control of several biological events including gene transcription, replication and cell proliferation. E2F-1 is a DNA-binding transcription factor which, upon interaction with its target DNA sequence, induces expression of several S phase specific genes all...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203011

    authors: Darbinian N,Gallia GL,Kundu M,Shcherbik N,Tretiakova A,Giordano A,Khalili K

    更新日期:1999-11-04 00:00:00

  • The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus.

    abstract::BPV-4 E5 inhibits transcription of the bovine MHC class I heavy chain (HC) gene, increases degradation of HC and downregulates surface expression of MHC class I by retaining the complex in the Golgi apparatus (GA). Here we report that transcription inhibition can be alleviated by interferon treatment and the degradati...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209245

    authors: Marchetti B,Ashrafi GH,Dornan ES,Araibi EH,Ellis SA,Campo MS

    更新日期:2006-04-06 00:00:00

  • A novel pro-apoptotic function of RACK1: suppression of Src activity in the intrinsic and Akt pathways.

    abstract::Earlier we showed that RACK1 regulates growth of human colon cells by suppressing Src activity at G(1) and mitotic checkpoints. Here, we show that RACK1 also induces apoptosis of the cells, partly by inhibiting Src. In the intrinsic pathway, RACK1 inhibits expression of anti-apoptotic Bcl-2 and Bcl-X(L), induces expre...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.293

    authors: Mamidipudi V,Cartwright CA

    更新日期:2009-12-17 00:00:00

  • Polyoma virus disrupts ARF signaling to p53.

    abstract::Polyoma virus (Py) differs from other small DNA tumor viruses in not encoding a protein that inactivates p53. The complete Py early region encoding the large T-antigen (PyLT), middle T-antigen (PyMT) and small T-antigen (PyST) will transform primary rodent cells and REF52 cells, but PyMT, the main Py oncogene, by itse...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204717

    authors: Lomax M,Fried M

    更新日期:2001-08-16 00:00:00

  • Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1.

    abstract::Steroid receptor co-activator-3 (SRC-3/AIB1) is an oncogene that is amplified and overexpressed in many human cancers. However, the molecular mechanisms that regulate 'activated SRC-3 oncoprotein' turnover during tumorigenesis remain to be elucidated. Here, we report that speckle-type POZ protein (SPOP), a cullin 3 (C...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.151

    authors: Li C,Ao J,Fu J,Lee DF,Xu J,Lonard D,O'Malley BW

    更新日期:2011-10-20 00:00:00

  • Live imaging of induced and controlled DNA double-strand break formation reveals extremely low repair by homologous recombination in human cells.

    abstract::DNA double-strand breaks (DSBs), the most hazardous DNA lesions, may result in genomic instability, a hallmark of cancer cells. The main DSB repair pathways are non-homologous end joining (NHEJ) and homologous recombination (HR). In mammalian cells, NHEJ, which can lead to inaccurate repair, predominates. HR repair (H...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.516

    authors: Shahar OD,Raghu Ram EV,Shimshoni E,Hareli S,Meshorer E,Goldberg M

    更新日期:2012-07-26 00:00:00

  • miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222.

    abstract::Non-small cell lung cancer (NSCLC) accounts for ∼80% of all lung cancers. Although some advances in lung cancer therapy have been made, patient survival is still quite poor. Two microRNAs, miR-221 and miR-222, upregulated by the MET proto-oncogene, have been already described to enhance cell survival and to induce TNF...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.260

    authors: Acunzo M,Visone R,Romano G,Veronese A,Lovat F,Palmieri D,Bottoni A,Garofalo M,Gasparini P,Condorelli G,Chiariello M,Croce CM

    更新日期:2012-02-02 00:00:00

  • K6 linked polyubiquitylation of FADD by CHIP prevents death inducing signaling complex formation suppressing cell death.

    abstract::Fas-associated death domain (FADD) is an adaptor protein recruiting complexes of caspase 8 to death ligand receptors to induce extrinsic apoptotic cell death in response to a TNF superfamily member. Although, formation of the complex of FADD and caspase 8 upon death stimuli has been studied in detail, posttranslationa...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0323-z

    authors: Seo J,Lee EW,Shin J,Seong D,Nam YW,Jeong M,Lee SH,Lee C,Song J

    更新日期:2018-09-01 00:00:00

  • Molecular organization and differential polyadenylation sites of the human ETS2 gene.

    abstract::The human ETS2 gene is a member of the ets gene family (ETS1, ETS2, ERG, ELK1 and ELK2) with amino acid similarity to the v-ets oncogene of the avian leukemia virus, E26. The ETS2 gene is composed of 10 exons, nine of which contribute to the open reading frame encoding 469 amino acids. The ETS2 gene directs the synthe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Watson DK,Mavrothalassitis GJ,Jorcyk CL,Smyth FE,Papas TS

    更新日期:1990-10-01 00:00:00

  • Role of the BLT2, a leukotriene B4 receptor, in Ras transformation.

    abstract::Oncogenic Ras is known to drive both the Rac and Raf-MAP-kinase pathways, which act in concert to cause cell transformation. Unlike the Raf-MAP-kinase cascade, however, the downstream elements of Rac pathway are not fully understood. Previously, we showed that cytosolic phospholipase A2 (cPLA2) and subsequent metaboli...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208151

    authors: Yoo MH,Song H,Woo CH,Kim H,Kim JH

    更新日期:2004-12-09 00:00:00

  • SIAH-1 interacts with CtIP and promotes its degradation by the proteasome pathway.

    abstract::SIAH-1 and SIAH-2 are the human members of an evolutionary highly conserved E3 ligase family. SIAH-1 is a p53 and p21(Waf-1/Cip-1) induced gene during apoptosis and tumor suppression. In stable-transfected clones of MCF-7 cells, SIAH-1 overexpression was associated with apoptosis, mitotic alterations and p21(Waf-1/Cip...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206994

    authors: Germani A,Prabel A,Mourah S,Podgorniak MP,Di Carlo A,Ehrlich R,Gisselbrecht S,Varin-Blank N,Calvo F,Bruzzoni-Giovanelli H

    更新日期:2003-12-04 00:00:00

  • Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells.

    abstract::Early growth response-1 (Egr-1) is overexpressed in human prostate tumors and contributes to cancer progression. On the other hand, mutation of p53 is associated with advanced prostate cancer, as well as with metastasis and hormone independence. This study shows that in prostate cell lines in culture, Egr-1 overexpres...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.24

    authors: Sauer L,Gitenay D,Vo C,Baron VT

    更新日期:2010-05-06 00:00:00

  • The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells.

    abstract::Wild-type (wt) p53 acts as a tumor suppressor, while certain mutant type (mt) p53 may exhibit 'oncogenic' function. We have recently demonstrated that human papillomavirus type 18 (HPV-18) E6 can partially overcome the growth-suppressive effects of wt p53, but it remains unclear what role p53 plays in cervical carcino...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Chen TM,Chen CA,Hsieh CY,Chang DY,Chen YH,Defendi V

    更新日期:1993-06-01 00:00:00

  • Notch-induced mammary tumorigenesis does not involve the lobule-limited epithelial progenitor.

    abstract::The mouse mammary epithelial cell hierarchy contains both multipotent stem cell as well as lineage-limited duct and lobular progenitor cell functions. The latter-also termed parity-identified mammary epithelial cells (PI-MECs)-are marked by beta-galactosidase (β Gal) expression following pregnancy and involution in wh...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.215

    authors: Bruno RD,Boulanger CA,Smith GH

    更新日期:2012-01-05 00:00:00

  • The topoisomerase I- and p53-binding protein topors is differentially expressed in normal and malignant human tissues and may function as a tumor suppressor.

    abstract::Topors was identified recently as a human protein that binds to topoisomerase I and p53. Topors contains a highly conserved RING domain and localizes in promyelocytic leukemia nuclear bodies. Relatively little is known regarding topors expression patterns or function. We now demonstrate that topors mRNA and protein ar...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207700

    authors: Saleem A,Dutta J,Malegaonkar D,Rasheed F,Rasheed Z,Rajendra R,Marshall H,Luo M,Li H,Rubin EH

    更新日期:2004-07-08 00:00:00

  • Fibroblast growth factor receptor-1 mediates chemotaxis independently of direct SH2-domain protein binding.

    abstract::Endothelial cells expressing fibroblast growth factor receptor-1 (FGFR-1) migrate and proliferate in response to treatment with FGF. We analysed ligand-induced migration and proliferation of porcine aortic endothelial cells expressing wild-type FGFR-1, point-mutated Y766F FGFR-1, unable to activate phospholipase C-gam...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201936

    authors: Landgren E,Klint P,Yokote K,Claesson-Welsh L

    更新日期:1998-07-23 00:00:00